ABI1 and leukemia: Moreover, the inhibition of Bcr-Abl-induced leukemia by Abi1 deficiency is independent of the sensitivity of these cells to imatinib, as the imatinib-tolerant p185Bcr-Abl cells also require Abi1 for development of leukemia in vivo.